Search reports.
Asia Pacific Nuclear Medicine Market Share, Industry | 2031
Get free sample report Request for Customiztion Buy Now

Asia Pacific Nuclear Medicine Market Share, Industry | 2031

Segments - Asia Pacific Nuclear Medicine Market by Products (Diagnostics [Positron Emission Tomography and Single Photon Emission Computed Tomography] and Therapeutics [Brachytherapy, Alpha Emitters, and Beta Emitters]), Applications (Oncology, Neurology, Cardiology, and Others), and Geography (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-4029 | 4.8 Rating | 81 Reviews | 159 Pages | Format : PDF Excel PPT

Report Description


Asia Pacific Nuclear Medicine Market Outlook 2031

The Asia Pacific nuclear medicine market size was USD 5.01 Billion in 2022 and is projected to reach USD 12.21 Billion by 2031 register a significant CAGR 10.4% during the forecast period, 2023–2031. The growth of the market is attributed to the high incidences of cancer & heart diseases and rising public knowledge about advanced healthcare system.

Nuclear medicine is a subset of molecular imaging primarily designed for diagnosing and treating of various diseases associated with cancer. It involves a procedure that use certain radioactive materials, also known as radiopharmaceuticals, to allow thorough examination of the conditions and functions of certain organs affected by cancer.

Asia Pacific Nuclear Medicine Market Outlook

This procedure is widely applied for treatment and diagnosis of some of the major cancer-originated diseases such as bone pain, thyroid cancer, hyperthyroidism, and lymphomas. The medicine can be administered in multiple ways but are widely done either invasive or oral modes. The radioisotopes are normally detected by nuclear medicine imaging, which is equipped with particular types of cameras linked to the computer that can offer accurate and high definition images of the targeted area of the body.

  • Increasing demand for biosimilar drugs as they are becoming more popular as a result of their low cost and wide availability. This is projected to drive the market in the coming years.
  • Rising prevalence of cancer and heart disorders among a large number of the population is expected to boost the market.
  • High number of the ageing population in the region along with growing awareness for several advanced treatment methods for several diseases is another key driver of the market.
  • Expensive diagnostic & therapeutic procedures using the imaging equipment is a major challenge that can hamper the market expansion during the projected period.
  • Uncertainty in the regulatory environment is another key restraining factor of the market.
  • Ongoing R&D programs and governments’ initiatives for healthcare system development in the region prove to be key opportunities for the market expansion.

Scope of The Asia Pacific Nuclear Medicine Market Report

The report on the Asia Pacific nuclear medicine market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Nuclear Medicine Market - Asia Pacific Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Products (Diagnostics [Positron Emission Tomography and Single Photon Emission Computed Tomography] and Therapeutics [Brachytherapy, Alpha Emitters, and Beta Emitters]) and Applications (Oncology, Neurology, Cardiology, and Others)

Geographical Scope

China, Japan, India, Australia, South Korea, and Rest of Asia Pacific

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

GE Healthcare; Curium SAS; Cardinal Health; Bracco Diagnostic Inc.; and Lantheus Medical Imaging

Asia Pacific Nuclear Medicine Market Segment Insights

Diagnostics segment is expected to grow at a rapid pace

Based on products, the Asia Pacific nuclear medicine market is bifurcated into diagnostics and therapeutics. The diagnostics segment is further divided into positron emission tomography (PET) and single photon emission computed tomography (SPECT) while the therapeutics segment is sub-classified as brachytherapy, alpha emitters, and beta emitters.

The diagnostics segment is expected to grow at a rapid pace during the forecast period due to the wide use of PET radioisotopes for diagnosis of the movement disorders, epilepsy, brain malignancies, dementia, stroke, and neural plasticity. Early detection of brain metastases, Parkinson syndromes, and neurodegenerative illnesses such as Alzheimer's disease is commonly conducted using the nuclear medicine methods.

Asia Pacific Nuclear Medicine Market Products

Cardiology segment is projected to expand at a considerable CAGR

On the basis of applications, the market is segregated into oncology, neurology, cardiology, and others. The cardiology segment is projected to expand at a considerable CAGR during the forecast period due to wide prevalence of cardiovascular diseases (CVDs) and rising occurrence of cardiac arrest. The cardiac nuclear medicine tests produce images of blood flow distribution to the heart muscle and can be used to assess heart function.

This approach can be used to diagnose angina, aneurysms, atherosclerosis, stroke, coronary artery disease, and congestive heart failure, which are derivatives of cardiovascular illnesses. It is also used to assess cardiomyopathy and detect cardiac damage caused by chemotherapy or radiotherapy. The main imaging instruments utilized in cardiac operations are gamma cameras and positron emission tomography scanners, while the SPECT imaging is primarily considered to be the gold standard for nuclear cardiology operations across the world.

Asia Pacific Nuclear Medicine Market Applications

China and India are anticipated to constitute a key market share

In terms of geography, the Asia Pacific nuclear medicine market is classified as China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. China and India are major economies in the region that held a large market share in 2020 and are anticipated to constitute a key market share in the coming years. Significant increase in the number of the ageing population and wide incidences of chronic illness such as CVDs among a large number of the population in these two countries.

Additionally, growing awareness about cancer and its requirement for sophisticated technology such as nuclear imaging for the treatment present another key driver of the regional market growth.

Segments

The Asia Pacific nuclear medicine market has been segmented on the basis of

Products

  • Diagnostics
  • Positron Emission Tomography
  • Single Photon Emission Computed Tomography
  • Therapeutics
  • Brachytherapy
  • Alpha Emitters
  • Beta Emitters

Application

  • Oncology
  • Neurology
  • Cardiology
  • Others

Geographical Scope

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Key Players

Competitive Landscape

Key players competing in the Asia Pacific nuclear medicine market are GE Healthcare; Curium SAS; Cardinal Health; Bracco Diagnostic Inc.; and Lantheus Medical Imaging. Some of the key players are constantly implementing several marketing strategies such as merge & acquisitions, capital investments, partnerships, and new product development to expand their consumer base worldwide.

Asia Pacific Nuclear Medicine Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nuclear Medicine Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Nuclear Medicine Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Nuclear Medicine Market - Supply Chain
  4.5. Global Nuclear Medicine Market Forecast
     4.5.1. Nuclear Medicine Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Nuclear Medicine Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Nuclear Medicine Market Absolute $ Opportunity
5. Global Nuclear Medicine Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Nuclear Medicine Market Size and Volume Forecast by Applications
     5.3.1. Oncology
     5.3.2. Neurology
     5.3.3. Cardiology
     5.3.4. Others
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Nuclear Medicine Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Nuclear Medicine Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Nuclear Medicine Demand Share Forecast, 2019-2026
7. North America Nuclear Medicine Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Nuclear Medicine Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Nuclear Medicine Market Size and Volume Forecast by Applications
     7.4.1. Oncology
     7.4.2. Neurology
     7.4.3. Cardiology
     7.4.4. Others
  7.5. Basis Point Share (BPS) Analysis by Applications
  7.6. Y-o-Y Growth Projections by Applications
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Nuclear Medicine Demand Share Forecast, 2019-2026
8. Latin America Nuclear Medicine Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Nuclear Medicine Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Nuclear Medicine Market Size and Volume Forecast by Applications
     8.4.1. Oncology
     8.4.2. Neurology
     8.4.3. Cardiology
     8.4.4. Others
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Nuclear Medicine Demand Share Forecast, 2019-2026
9. Europe Nuclear Medicine Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Nuclear Medicine Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Nuclear Medicine Market Size and Volume Forecast by Applications
     9.4.1. Oncology
     9.4.2. Neurology
     9.4.3. Cardiology
     9.4.4. Others
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Nuclear Medicine Demand Share Forecast, 2019-2026
10. Asia Pacific Nuclear Medicine Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Nuclear Medicine Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Nuclear Medicine Market Size and Volume Forecast by Applications
     10.4.1. Oncology
     10.4.2. Neurology
     10.4.3. Cardiology
     10.4.4. Others
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Nuclear Medicine Demand Share Forecast, 2019-2026
11. Middle East & Africa Nuclear Medicine Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Nuclear Medicine Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Nuclear Medicine Market Size and Volume Forecast by Applications
     11.4.1. Oncology
     11.4.2. Neurology
     11.4.3. Cardiology
     11.4.4. Others
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Nuclear Medicine Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Nuclear Medicine Market: Market Share Analysis
  12.2. Nuclear Medicine Distributors and Customers
  12.3. Nuclear Medicine Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. GE Healthcare
     12.4.2. Curium SAS
     12.4.3. Cardinal Health
     12.4.4. Bracco Diagnostic Inc.
     12.4.5. Lantheus Medical Imaging

Methodology

Our Clients

Siemens Healthcare
Pfizer
Nestle SA
Dassault Aviation
FedEx Logistics
Honda Motor Co. Ltd.
sinopec
Microsoft